NEW YORK (TheStreet) -- RATINGS CHANGES

Baidu (BIDU - Get Report) was downgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: BIDU Ratings Report.

Blue Buffalo (BUFF) was upgraded to overweight from equal-weight at Morgan Stanley. $24 price target. The stock is down 40% from summer highs and not giving the company enough credit for its growth potential, Morgan Stanley said.

Celanese (CE - Get Report) was downgraded to neutral from buy at Goldman Sachs. $71 price target. This was a valuation call, as the company could face some margin compression, said Goldman.

Charles River (CRL - Get Report) was upgraded to market perform from underperform at Wells Fargo. Recent checks show that business is stable and the company will continue to benefit from a weaker Canadian dollar, Wells said.

EMC (EMC) was downgraded to hold at Jefferies. This was a valuation call, based on a $29 price target.

Halyard Health (HYH) was downgraded to underweight at Morgan Stanley. $27 price target. The company looks ready for double-digit declines to 2016 consensus estimates, Morgan said.

Coffee Holding (JVA - Get Report) was downgraded to sell at TheStreet Ratings. You can view the full analysis from the report here: JVA Ratings Report.

NetApp (NTAP - Get Report) was upgraded to outperform from neutral at Robert Baird. $40 price target. Fundamentals are improving and the company is a potential takeover target, Baird said.

PPG (PPG - Get Report) was upgraded to buy from neutral at Goldman Sachs. $113 price target. This was a valuation call, as the stock is down 18% in the past three months, Goldman said.

Ruckus Wireless (RKUS) was downgraded to neutral from overweight at Piper Jaffray. This was a valuation call, based on a $13 price target, Piper said.

Ralph Lauren (RL - Get Report) was initiated with an outperform rating at Telsey Advisory. $142 price target. The company is seeing lower currency pressures and will continue to expand internationally, said Telsey.

Exxon Mobil (XOM - Get Report) was upgraded to overweight from underweight at Barclays. $85 price target. The company has a relatively high dividend yield, which has historically led to outperformance, Barclays said.

 

This article was written by a staff member of TheStreet.